Lista de obras - Brendon Chua - Dominio Público Uruguay

A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals

artículo científico publicado en 2010

A single dose biodegradable vaccine depot that induces persistently high levels of antibody over a year.

artículo científico publicado en 2015

Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 Agonists.

artículo científico publicado en 2018

CD8<sup>+</sup> T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity

artículo científico publicado en 2021

Chitosan Microparticles and Nanoparticles as Biocompatible Delivery Vehicles for Peptide and Protein-Based Immunocontraceptive Vaccines

scientific article published on 16 December 2011

Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups

artículo científico publicado en 2006

Considerations for the rapid deployment of vaccines against H7N9 influenza.

artículo científico publicado en 2014

Control of size dispersity of chitosan biopolymer microparticles and nanoparticles to influence vaccine trafficking and cell uptake

artículo científico publicado en 2012

Dendritic cell acquisition of epitope cargo mediated by simple cationic peptide structures

artículo científico publicado en 2008

Electrostatic-mediated enhancement of protein antigen immunogenicity using charged TLR2-targeting lipopeptides

artículo científico publicado en 2012

Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.

artículo científico publicado en 2015

Generation of Adaptive Immune Responses Following Influenza Virus Challenge is Not Compromised by Pre-Treatment with the TLR-2 Agonist Pam2Cys

artículo científico publicado en 2015

Geometry of a TLR2-Agonist-Based Adjuvant Can Affect the Resulting Antigen-Specific Immune Response

artículo científico publicado en 2019

Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responses

artículo científico publicado en 2012

Human CD8+ T cell cross-reactivity across influenza A, B and C viruses

scientific article published on 18 February 2019

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.

artículo científico publicado en 2018

Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity

artículo científico publicado en 2015

Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus.

artículo científico publicado en 2003

Opinion: Making Inactivated and Subunit-Based Vaccines Work

artículo científico publicado en 2018

Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses

artículo científico publicado en 2015

PEGylation of a TLR2-agonist-based vaccine delivery system improves antigen trafficking and the magnitude of ensuing antibody and CD8+ T cell responses

artículo científico publicado en 2017

Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses

scientific article published on 02 July 2019

Reducing the impact of influenza-associated secondary pneumococcal infections.

artículo científico publicado en 2015

Soluble proteins induce strong CD8+ T cell and antibody responses through electrostatic association with simple cationic or anionic lipopeptides that target TLR2.

artículo científico publicado en 2011

Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys

artículo científico publicado en 2010

Structure-function relationships of protein-lipopeptide complexes and influence on immunogenicity

artículo científico publicado en 2017

Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype

artículo científico publicado en 2020

Synthesis of toll-like receptor-2 targeting lipopeptides as self-adjuvanting vaccines

artículo científico publicado en 2008

The Toll-Like Receptor 2 agonist PEG-PamCys as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasites

article

The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responses

artículo científico publicado en 2014

Lista de obras de Brendon Chua

A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals

A single dose biodegradable vaccine depot that induces persistently high levels of antibody over a year.

Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 Agonists.

CD8<sup>+</sup> T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity

Chitosan Microparticles and Nanoparticles as Biocompatible Delivery Vehicles for Peptide and Protein-Based Immunocontraceptive Vaccines

Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups

Considerations for the rapid deployment of vaccines against H7N9 influenza.

Control of size dispersity of chitosan biopolymer microparticles and nanoparticles to influence vaccine trafficking and cell uptake

Dendritic cell acquisition of epitope cargo mediated by simple cationic peptide structures

Electrostatic-mediated enhancement of protein antigen immunogenicity using charged TLR2-targeting lipopeptides

Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.

Generation of Adaptive Immune Responses Following Influenza Virus Challenge is Not Compromised by Pre-Treatment with the TLR-2 Agonist Pam2Cys

Geometry of a TLR2-Agonist-Based Adjuvant Can Affect the Resulting Antigen-Specific Immune Response

Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responses

Human CD8+ T cell cross-reactivity across influenza A, B and C viruses

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.

Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity

Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus.

Opinion: Making Inactivated and Subunit-Based Vaccines Work

Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses

PEGylation of a TLR2-agonist-based vaccine delivery system improves antigen trafficking and the magnitude of ensuing antibody and CD8+ T cell responses

Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses

Reducing the impact of influenza-associated secondary pneumococcal infections.

Soluble proteins induce strong CD8+ T cell and antibody responses through electrostatic association with simple cationic or anionic lipopeptides that target TLR2.

Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys

Structure-function relationships of protein-lipopeptide complexes and influence on immunogenicity

Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype

Synthesis of toll-like receptor-2 targeting lipopeptides as self-adjuvanting vaccines

The Toll-Like Receptor 2 agonist PEG-PamCys as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasites

The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responses